Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

M-ficolin levels reflect disease activity and predict remission in early rheumatoid arthritis

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Reply

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Abatacept after Rituximab in rheumatoid arthritis. a Pan-European Collaboration of RA Registries.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  3. Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Christian Gytz Ammitzbøll
  • Steffen Thiel
  • Jens Christian Jensenius
  • Torkell Juulsgaad Ellingsen
  • Kim Hørslev-Petersen
  • Merete L Hetland
  • Michael Peter Junker
  • Niels Steen Krogh
  • Mikkel Østergaard
  • Kristian Stengaard-Pedersen
View graph of relations
To assess plasma M-ficolin concentrations in disease-modifying antirheumatic drug (DMARD)-naive patients with early rheumatoid arthritis (RA), to investigate the correlation of M-ficolin concentrations with disease activity markers, and to determine the predictive value of M-ficolin with respect to the Disease Activity Score in 28 joints (DAS28).
Original languageEnglish
JournalArthritis & Rheumatism
Volume65
Issue number12
Pages (from-to)3045-50
Number of pages6
ISSN0004-3591
DOIs
Publication statusPublished - Dec 2013

    Research areas

  • Adult, Aged, Antibodies, Monoclonal, Humanized, Antirheumatic Agents, Arthritis, Rheumatoid, Drug Therapy, Combination, Female, Humans, Lectins, Male, Methotrexate, Middle Aged, Predictive Value of Tests, Remission Induction, Severity of Illness Index, Treatment Outcome

ID: 42978579